February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
July 2026
The global infectious disease vaccines market size is estimated to hit around USD 77.04 billion by 2035 increasing from USD 38.83 billion in 2025, with a CAGR of 7.09%.
February 2026
The global respiratory disease vaccine market size was calculated at USD 101.10 billion in 2025 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
June 2026
The global vaccine storage and packaging market size is estimated to hit around USD 39.24 billion by 2035 increasing from USD 23.29 billion in 2025, with a CAGR of 5.36%.
June 2026
The global foot and ankle devices market size surpassed USD 5.42 billion in 2025 and is expected to hit around USD 10.48 billion by 2035 with a CAGR of 6.82%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
July 2026
The lyme disease diagnostic devices market size accounted for USD 2.82 billion in 2025 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
July 2026
The global veterinary clostridium vaccine market size was evaluated at USD 908.96 billion in 2025 and is predicted to hit around USD 3,196.50 billion by 2035, growing at a CAGR of 13.40%.
July 2026
The global anthrax vaccine market size was evaluated at USD 14.18 billion in 2025 and is predicted to hit around USD 22.34 billion by 2035, growing at a CAGR of 4.65%.
July 2026
The global luxury footwear market size was estimated at USD 41.38 billion in 2025 and is expected to surge around USD 81.14 billion by 2035, with a CAGR of 6.97%.
July 2026
The global carbon footprint assessment services market size expands as organizations rely on advanced tools to measure emissions, improve sustainability, and achieve climate compliance.
July 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
July 2026
The global low-carbon footprint coatings market size driven by sustainable materials, strict environmental rules, and growing demand for energy-efficient coating solutions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global measles, mumps, rubella vaccine market size is estimated at USD 2.02 billion in 2025 and is expected to hit around USD 4.53 billion by 2035, growing at a CAGR of 8.41%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global feline vaccines market size is estimated to hit around USD 3.49 billion by 2035 increasing from USD 1.77 billion in 2025, with a CAGR of 7.02%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The US diabetic foot ulcer treatment market size was evaluated at USD 3.66 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 6.04%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global vaccine technologies market size is estimated to hit around USD 102.88 billion by 2035 increasing from USD 55.01 billion in 2025, with a CAGR of 6.46%.
June 2026
The global mouth ulcer treatment market size was calculated at USD 1.68 billion in 2025 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com